Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
Pre-publication versions of this article are available by contacting email@example.com.
|11 Jan 2017||Submitted||Original manuscript|
|26 Jan 2017||Reviewed||Reviewer Report - Joop E Arends|
|3 Feb 2017||Reviewed||Reviewer Report - Roberto Rossotti|
|4 Feb 2017||Reviewed||Reviewer Report - Mario Masarone|
|7 Feb 2017||Reviewed||Reviewer Report - Fabienne Marcellin|
|9 May 2017||Author responded||Author comments - Evan Cunningham|
|Resubmission - Version 2|
|9 May 2017||Submitted||Manuscript version 2|
|31 May 2017||Author responded||Author comments - Evan Cunningham|
|Resubmission - Version 3|
|31 May 2017||Submitted||Manuscript version 3|
|1 Jun 2017||Editorially accepted|
|13 Jun 2017||Article published||10.1186/s12879-017-2517-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.